Prostate Cancer - Results from #20

Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortium. March 24, 2025

Prognostic value of [18F]FDG- and PSMA-PET in patients evaluated for [177Lu]Lu-PSMA therapy of mCRPC. March 24, 2025

Microultrasonography-Guided vs MRI-Guided Biopsy for Prostate Cancer Diagnosis: The OPTIMUM Randomized Clinical Trial. March 24, 2025

FDA Approves New Prostate Cancer Imaging Agent Gozellix® March 21, 2025

Prevalence of Mismatch Repair Deficiency in Primary Prostate Cancer in a Large Prospective Cohort. March 21, 2025

Real-world treatment patterns and genetic testing in a metastatic castration-resistant prostate cancer setting in Europe. March 21, 2025

A simplified MyProstateScore2.0 for high-grade prostate cancer. March 21, 2025

Tumor burden and heterogenous treatment effect of apalutamide in metastatic castration-sensitive prostate cancer. March 21, 2025

Predictive Model of Acute Rectal Toxicity in Prostate Cancer Treated With Radiotherapy. March 21, 2025

A Phase II, Single Arm, Multicentre Trial of Triamcinolone With a GnRH Analog for Castrate-Resistant Prostate Cancer (TRICREST). March 20, 2025

Risk-stratified Approach to Implementing Population-based Prostate Cancer Screening in Five Pilot Sites in the European Union: A Protocol for the PRAISE-U Project. March 20, 2025

Apalutamide use in metastatic hormone-sensitive prostate cancer patients diagnosed by conventional and next-generation imaging. Real world data from 772 patients. March 20, 2025

Olaparib Plus Abiraterone in Asian Patients With Metastatic Castration-Resistant Prostate Cancer: PROpel Subset Analysis. March 20, 2025

Outcome of Subsequent Therapies After 177Lu-Vipivotide Tetraxetan for Metastatic Castrate-Resistant Prostate Cancer: A Tertiary Cancer Center Experience. March 20, 2025

Defeating lethal cancer: Interrupting the ecologic and evolutionary basis of death from malignancy. March 20, 2025

"Hope at a better chance": perspectives on genetic counseling and testing among black individuals with prostate cancer. March 19, 2025

Low incidence of significant hydrogel spacer rectal wall infiltration: results from an experienced high-volume center. March 19, 2025

Hypofractionated radiotherapy in elderly patients (≥75 years) affected by localized prostate cancer: a multicenter retrospective analysis from the IPOPROMISE study. March 19, 2025

Time for action: actinium-225 PSMA-targeted alpha therapy for metastatic prostate cancer - a systematic review and meta-analysis. March 19, 2025

The Negative Predictive Value of a Prostate MRI in Black Men: Implications for Biopsy Decision-Making. March 19, 2025

Page 2 of 1467